Cost per treatment responder analysis of atogepant compared to rimegepant for the preventive treatment of episodic migraine

To estimate the number needed to treat and cost per additional responder for atogepant and rimegepant versus placebo for the preventive treatment of episodic migraine (EM) in the United States.